Notably, miR-221-3p has been reported to act as a tumor promoter in multiple types of cancers, involved in tumor invasion, metastasis, proliferation and chemotherapy resistance by regulating the expression of target genes such as VASH1, PARP1, RB1 [26–28]. The gene discussed is RB1; the disease is neoplasm.